## Abstract Antibodies against hepatitis C virus (antiβHCV) were detected in 60.8% of 78 patients with hepatocellular carcinoma (HCC). Cirrhosis, present in most of the patients, as well as alcohol abuse, age, sex, and Ξ±βfetoprotein were equally distributed in the antiβHCVβpositive and βnegative gr
Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma
β Scribed by Nobukazu Yuki; Norio Hayashi; Akinori Kasahara; Hideki Hagiwara; Kazuhiro Katayama; Hideyuki Fusamoto; Takenobu Kamada
- Book ID
- 112513227
- Publisher
- Springer US
- Year
- 1992
- Tongue
- English
- Weight
- 701 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antibody to hepatitis C virus (anti-HCV) was detected in 18.7% of patients with hepatocellular carcinoma (HCC) and in 10.9% of controls (P<O.OOl). The corresponding prevalences of hepatitis B surface antigen (HBsAg) were 59.3% and 50.0% (F'CO.001). Using patients with non-hepatic disease as controls
## BACKGROUND. The effect of prior hepatitis B virus (HBV) infection on the clinicopathologic findings for patients with hepatitis C virus (HCV) RNA and hepatocellular carcinoma (HCC) is still unclear. ## METHODS. Of 59 patients who underwent liver resection for HCV-related HCC (Υ 2.0 cm in greate